Sanlı Y[au] - Search Results

Year	Number of Results
1977	1
2005	3
2006	6
2007	4
2008	3
2009	2
2010	1
2011	4
2012	7
2013	3
2014	1
2015	3
2016	5
2017	7
2018	4
2019	5
2020	5
2021	17
2022	9
2023	11
2024	6

1

Neuroendocrine Tumor Diagnosis and Management: ⁶⁸Ga-DOTATATE PET/CT.

Sanli Y, Garg I, Kandathil A, Kendi T, Zanetti MJB, Kuyumcu S, Subramaniam RM. Sanli Y, et al. AJR Am J Roentgenol. 2018 Aug;211(2):267-277. doi: 10.2214/AJR.18.19881. Epub 2018 Jul 5. AJR Am J Roentgenol. 2018. PMID: 29975116 Review.

2

Gastro-Enteric-Pancreatic Neuroendocrine Tumor Treatment: ¹⁷⁷Lu-DOTATATE.

Sanli Y, Denizmen D, Subramaniam RM. Sanli Y, et al. PET Clin. 2023 Apr;18(2):201-214. doi: 10.1016/j.cpet.2022.11.002. PET Clin. 2023. PMID: 36858745 Review.

3

¹⁷⁷Lu-PSMA Therapy in Metastatic Castration-Resistant Prostate Cancer.

Sanli Y, Simsek DH, Sanli O, Subramaniam RM, Kendi AT. Sanli Y, et al. Biomedicines. 2021 Apr 15;9(4):430. doi: 10.3390/biomedicines9040430. Biomedicines. 2021. PMID: 33921146 Free PMC article. Review.

4

Fibroblast-Activated Protein Inhibitor PET/CT: Cancer Diagnosis and Management.

Kuyumcu S, Sanli Y, Subramaniam RM. Kuyumcu S, et al. Among authors: sanli y. Front Oncol. 2021 Nov 11;11:758958. doi: 10.3389/fonc.2021.758958. eCollection 2021. Front Oncol. 2021. PMID: 34858834 Free PMC article. Review.

5

Precision Medicine and PET-Computed Tomography in Pediatric Malignancies.

Sanli Y, Yilmaz E, Subramaniam RM. Sanli Y, et al. PET Clin. 2017 Oct;12(4):423-435. doi: 10.1016/j.cpet.2017.05.009. Epub 2017 Jul 28. PET Clin. 2017. PMID: 28867113 Review.

6

Precision Medicine and PET/Computed Tomography in Melanoma.

Mena E, Sanli Y, Marcus C, Subramaniam RM. Mena E, et al. Among authors: sanli y. PET Clin. 2017 Oct;12(4):449-458. doi: 10.1016/j.cpet.2017.05.002. Epub 2017 Jul 14. PET Clin. 2017. PMID: 28867115 Free PMC article. Review.

7

Update 2018: 18F-FDG PET/CT and PET/MRI in Head and Neck Cancer.

Sanli Y, Zukotynski K, Mittra E, Chen DL, Nadel H, Niederkohr RD, Subramaniam RM. Sanli Y, et al. Clin Nucl Med. 2018 Dec;43(12):e439-e452. doi: 10.1097/RLU.0000000000002247. Clin Nucl Med. 2018. PMID: 30394934 Review.

8

Neoadjuvant intermediate-course versus long-course chemoradiotherapy in T3-4/N0+ rectal cancer: Istanbul R-02 phase II randomized study.

Senyurek S, Saglam S, Saglam EK, Yanar H, Gok K, Tastekin D, Akbas CK, Sakin ND, Kartal GD, Balik E, Keskin M, Sanli Y, Gulluoglu M, Akgun Z. Senyurek S, et al. Among authors: sanli y. Oncol Res. 2023 Jul 21;31(5):689-696. doi: 10.32604/or.2023.030351. eCollection 2023. Oncol Res. 2023. PMID: 37547762 Free PMC article. Clinical Trial.

9

68Ga-PSMA PET/CT and PET/MRI in high-risk prostate cancer patients.

Sanli Y, Sanli O, Has Simsek D, Subramaniam RM. Sanli Y, et al. Nucl Med Commun. 2018 Oct;39(10):871-880. doi: 10.1097/MNM.0000000000000888. Nucl Med Commun. 2018. PMID: 30124601 Review.

10

The role of [⁶⁸ Ga]Ga-FAPI-04 PET/CT in renal cell carcinoma: a preliminary study.

Civan C, Kuyumcu S, Has Simsek D, Sanli O, Isik EG, Ozkan ZG, Hurdogan O, Sanli Y. Civan C, et al. Among authors: sanli y. Eur J Nucl Med Mol Imaging. 2024 Feb;51(3):852-861. doi: 10.1007/s00259-023-06461-4. Epub 2023 Oct 7. Eur J Nucl Med Mol Imaging. 2024. PMID: 37803246

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

96 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

96 results

Results by year